Treatment and prevention of bacteriuria in patients on median-term transurethral catheterization.
Vollaard
E J
EJ
Department of Pharmacy, Canisius-Wilhelmina Hospital, St. Annastraat 289, 6525 GT Nijmegen, The Netherlands.
Clasener
H A
HA
Verkeyn
J M
JM
Zambon
J V
JV
Joosten
H J
HJ
Van Griethuysen
A J
AJ
D000368:Aged; D000369:Aged, 80 and over; D000666:Amphotericin B / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001437:Bacteriuria / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D009582:Nitrofurantoin / Q000627:therapeutic use; D050611:Sodium-Phosphate Cotransporter Proteins, Type III; D013997:Time Factors; D014521:Urethra; D014546:Urinary Catheterization / Q000009:adverse effects* / Q000379:methods
D000890:Anti-Infective Agents; D050611:Sodium-Phosphate Cotransporter Proteins, Type III; D000666:Amphotericin B; D009582:Nitrofurantoin